These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16375745)

  • 1. Recent developments of structure based beta-secretase inhibitors for Alzheimer's disease.
    Ghosh AK; Kumaragurubaran N; Tang J
    Curr Top Med Chem; 2005; 5(16):1609-22. PubMed ID: 16375745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BACE1: the beta-secretase enzyme in Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2004; 23(1-2):105-14. PubMed ID: 15126696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-secretase (BACE) as a drug target for Alzheimer's disease.
    Vassar R
    Adv Drug Deliv Rev; 2002 Dec; 54(12):1589-602. PubMed ID: 12453676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beta-secretase, BACE: a prime drug target for Alzheimer's disease.
    Vassar R
    J Mol Neurosci; 2001 Oct; 17(2):157-70. PubMed ID: 11816789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of BACE1 inhibitors for Alzheimer's disease.
    Guo T; Hobbs DW
    Curr Med Chem; 2006; 13(15):1811-29. PubMed ID: 16787223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.
    Yan R; Bienkowski MJ; Shuck ME; Miao H; Tory MC; Pauley AM; Brashier JR; Stratman NC; Mathews WR; Buhl AE; Carter DB; Tomasselli AG; Parodi LA; Heinrikson RL; Gurney ME
    Nature; 1999 Dec; 402(6761):533-7. PubMed ID: 10591213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting presenilin-type aspartic protease signal peptide peptidase with gamma-secretase inhibitors.
    Weihofen A; Lemberg MK; Friedmann E; Rueeger H; Schmitz A; Paganetti P; Rovelli G; Martoglio B
    J Biol Chem; 2003 May; 278(19):16528-33. PubMed ID: 12621027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of memapsin 2 (beta-secretase) and strategy of inhibitor design.
    Tang J; Ghosh AK; Hong L; Koelsch G; Turner RT; Chang W
    J Mol Neurosci; 2003; 20(3):299-304. PubMed ID: 14501012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The search for gamma-secretase and development of inhibitors.
    Tsai JY; Wolfe MS; Xia W
    Curr Med Chem; 2002 Jun; 9(11):1087-106. PubMed ID: 12052174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Secretase, APP and Abeta in Alzheimer's disease.
    Vassar R
    Subcell Biochem; 2005; 38():79-103. PubMed ID: 15709474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.
    Vassar R; Bennett BD; Babu-Khan S; Kahn S; Mendiaz EA; Denis P; Teplow DB; Ross S; Amarante P; Loeloff R; Luo Y; Fisher S; Fuller J; Edenson S; Lile J; Jarosinski MA; Biere AL; Curran E; Burgess T; Louis JC; Collins F; Treanor J; Rogers G; Citron M
    Science; 1999 Oct; 286(5440):735-41. PubMed ID: 10531052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BACE inhibitors as potential therapeutics for Alzheimer's disease.
    Evin G; Kenche VB
    Recent Pat CNS Drug Discov; 2007 Nov; 2(3):188-99. PubMed ID: 18221231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer's disease.
    Moussa CE
    Expert Opin Investig Drugs; 2017 Oct; 26(10):1131-1136. PubMed ID: 28817311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of BACE, a promising approach to Alzheimer's disease therapy.
    Roggo S
    Curr Top Med Chem; 2002 Apr; 2(4):359-70. PubMed ID: 11966460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gamma-secretase as a therapeutic target for treatment of Alzheimer's disease.
    Tomita T; Iwatsubo T
    Curr Pharm Des; 2006; 12(6):661-70. PubMed ID: 16472155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein.
    Lin X; Koelsch G; Wu S; Downs D; Dashti A; Tang J
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1456-60. PubMed ID: 10677483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of BACE1 for therapeutic use in Alzheimer's disease.
    Luo X; Yan R
    Int J Clin Exp Pathol; 2010 Jul; 3(6):618-28. PubMed ID: 20661410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes.
    Sun X; Wang Y; Qing H; Christensen MA; Liu Y; Zhou W; Tong Y; Xiao C; Huang Y; Zhang S; Liu X; Song W
    FASEB J; 2005 May; 19(7):739-49. PubMed ID: 15857888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretases as therapeutic targets for the treatment of Alzheimer's disease.
    Dominguez DI; De Strooper B; Annaert W
    Amyloid; 2001 Jun; 8(2):124-42. PubMed ID: 11409035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.